Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C | Nature Reviews Gastroenterology & Hepatology
Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study | PLOS ONE
Que faisons nous ? — Centre International de Recherche en Infectiologie
Add-on pegylated interferon augments hepatitis B surface antigen clearance vs continuous nucleos(t)ide analog monotherapy in Chinese patients with chronic hepatitis B and hepatitis B surface antigen ≤ 1500 IU/mL: An observational study
In Vivo Pharmacology and Toxicology Evaluation of Polyethylene Glycol-Conjugated Interferon β-1a | Journal of Pharmacology and Experimental Therapeutics
Add-on, switch-to PEG-IFN therapy strategies improve serological response in CHB patients | Latest news for Doctors, Nurses and Pharmacists | Pharmacy
Raised Serum Transaminases during Treatment with Pegylated Interferon for Chronic Hepatitis C
ASPIRE Study: SMV + PEG-IFN + RBV for genotype 1 experienced patients - ppt download
Pharmacokinetic and pharmacodynamic comparison of two "pegylated" interferon alpha-2 formulations in healthy male volunteers: a randomized, crossover, double-blind study | BMC Pharmacology | Full Text
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
Consensus on Pegylated Interferon Alpha in Treatment of Chronic Hepatitis B
:max_bytes(150000):strip_icc()/pegasys-568530305f9b586a9e15ec79.jpg "Pegylated Interferon: Definition, Types, Uses")
Pegylated Interferon: Definition, Types, Uses
Frontiers | Interferon and Hepatitis B: Current and Future Perspectives
Peginterferon Alfa-2a (40 kD) Stopping Rules in Chronic Hepatitis B: A Systematic Review and Meta-Analysis of Individual Participant Data - Vedran Pavlovic, Lei Yang, Henry Lik-Yuen Chan, Jinlin Hou, Harry L Janssen,
Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial | Scientific Reports
Characterization and biologic activity of PPB-PEG-IFN-γ. A) Schematic... | Download Scientific Diagram
Case Study 1: Relapser to PEG IFN-Alfa + RBV (Slides With Transcript)
Chronic treatment with peg-IFN-α reduces peripheral disease parameters... | Download Scientific Diagram
Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study - ScienceDirect
Pegylated interferon-α inhibits the proliferation of hepatocellular carcinoma cells by downregulating miR-155 | Annals of Hepatology
Peg-INF – Ferozsons Laboratories Limited
EP1087778B1 - Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c - Google Patents
![PDF] Consensus Consensus on Pegylated Interferon Alpha in Treatment of Chronic Hepatitis B | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/773a2ed1c92ed98831267442933ac3793394f2a7/4-Figure1-1.png "PDF] Consensus Consensus on Pegylated Interferon Alpha in Treatment of Chronic Hepatitis B | Semantic Scholar")
PDF] Consensus Consensus on Pegylated Interferon Alpha in Treatment of Chronic Hepatitis B | Semantic Scholar
Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion | PLOS ONE
